Skip to main content
Screener/Healthcare/Biotechnology

BTAI — BioXcel Therapeutics, Inc.

NASDAQ
$0.19-0.53 (-74.11%)
Penny StockUnder $1Under $5Healthcare
$0.16
$4.29
$0.16
$0.23
EPS (TTM)$-6.70
P/E Ratio-0.19
Dividend Yield—
Market Cap$24.1M
Volume56.12M
Prev Close$0.72
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q1 '26$206K-$12.7M$-1.04-65.5%-6160.7%
Q4 '25$256K-$12.5M$-1.0358.6%-4900.4%
Q3 '25$98K-$30.9M$-2.1812.2%-31541.8%
Q2 '25$120K-$19.2M$-2.4510.8%-15989.2%
Q1 '25$168K-$7.3M$-1.5091.7%-4317.9%
Q4 '24$366K-$10.9M$-3.57-127.3%-2966.9%
Q3 '24$214K-$13.7M$-5.15-446.7%-6378.5%
Q2 '24$1.1M-$8.3M$-3.3094.4%-751.7%
Get Your Daily Market Recap